TrialClinical drug investigation2016

Exposure-Efficacy Analyses of Ombitasvir, Paritaprevir/Ritonavir with Dasabuvir ± Ribavirin in HCV Genotype 1-Infected Patients.

Amit Khatri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.